Science
MD Anderson’s Therapeutics Discovery Division, Orionis Biosciences Launch Project Helios to Advance Novel Small-Molecule Cancer Medicines – Press Release – Digital Journal
Combining Orionis’ unique high-throughput drug discovery technologies with the Therapeutics Discovery division’s expertise in small-molecule therapies and translational…
BOSTON & GHENT, Belgium & HOUSTON–(Business Wire)–Orionis Biosciences, a life sciences company pioneering innovation in genome-scale drug discovery, and The University of Texas MD Anderson Cancer Centers Therapeutics Discovery division today announced the launch of Project Helios, a research collaboration designed to unlock new drug development opportunities through genome-scale mapping of drug-target interactions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210309005121/en/
…
-
Noosa News15 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Business16 hours agoASX 200 lifts on the RBA’s latest interest rate call
-
Noosa News24 hours agoFarmers sell off record numbers of stock as southern NSW drought bites
-
Noosa News18 hours agoNo conviction recorded for teen behind attack on Peter Dutton’s office